Alex Nivorozhkin

Title: **Alex Nivorozhkin: Pioneering Innovations in Pharmacology**

Introduction

Alex Nivorozhkin, based in West Roxbury, MA, is a notable inventor with an impressive portfolio of 25 patents. His work primarily focuses on the development of chemical compounds aimed at advancing medical treatments, particularly in relation to psychological and central nervous system disorders.

Latest Patents

Among his latest contributions to the field of pharmacology are two significant patents. The first is for "Deuterated tryptamine derivatives and methods of use," which explores chemical compounds targeting the serotonin 5-HT receptor, showcasing potential in treating various related diseases. The second, "Therapeutic phenethylamine compositions and methods of use," involves deuterated 2C—X phenethylamine compounds that are utilized in treating disorders associated with the same serotonin receptor. This patent also details pharmaceutical compositions, including tablet compositions and kits, and innovative methods for delivering the compounds via inhalation.

Career Highlights

Alex has made substantial strides in his career, having worked with esteemed organizations such as Amorsa Therapeutics, Inc. and Cybin Irl Limited. His efforts in these companies emphasize his dedication to translating scientific research into viable therapeutic solutions.

Collaborations

Throughout his career, Alex has partnered with various professionals in the field, including notable coworkers Nelson Landrau and Michael Palfreyman. These collaborations have enriched his work and fostered advancements in the therapeutic applications of his inventions.

Conclusion

In summary, Alex Nivorozhkin stands out as a prominent inventor in the pharmacological arena, with a significant body of work that evidences his commitment to improving health outcomes through innovative chemical compounds. His ongoing dedication to research and development continues to hold promise for addressing complex medical challenges.